How ILC2s Affect Eosinophilic Esophagitis
Author Information
Author(s): Lim MinYeong, Kim Taesoo, Kim Hyesung, Jang Bo Gun, Myung Jae Kyung, Kim Hye Young
Primary Institution: Seoul National University College of Medicine
Hypothesis
The study investigates the role of ILC2s in the pathogenesis of eosinophilic esophagitis (EoE) through Areg-EGFR signaling.
Conclusion
ILC2-derived amphiregulin promotes abnormal epithelial remodeling in eosinophilic esophagitis by activating the EGFR signaling pathway.
Supporting Evidence
- ILC2s were found to be abundant in the esophagus of EoE patients.
- Blocking Areg-EGFR signaling reduced epithelial thickening in EoE models.
- ILC2-derived Areg was shown to activate EGFR in esophageal epithelial cells.
Takeaway
This study shows that certain immune cells in the esophagus can cause problems when they produce a specific protein, leading to thickening of the esophagus.
Methodology
The study used murine models and human biopsies to analyze the role of ILC2s and their cytokine production in EoE.
Limitations
The study primarily focuses on murine models, which may not fully replicate human disease mechanisms.
Participant Demographics
The study included 22 patients with eosinophilic esophagitis and 10 patients with GERD.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website